We are live on
!
Find out more
Russell Investments Group Portfolio holdings
AUM
$114B
1-Year Est. Return
41.71%
This Fund
S&P 500
This Quarter
Est. Return
-13.83%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
–
AUM
$49B
AUM Growth
-$8.48B
(-15%)
Cap. Flow
+$10.7B
Cap. Flow
% of AUM
21.85%
Top 10 Holdings %
Top 10 Hldgs %
14.83%
Holding
3,035
New
269
Increased
1,096
Reduced
1,170
Closed
157
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$94M |
| 2 |
Corteva
CTVA
|
+$81.7M |
| 3 |
Pfizer
PFE
|
+$77.5M |
| 4 |
WRK
WestRock Company
WRK
|
+$67.1M |
| 5 |
Walmart Inc
WMT
|
+$57.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.83% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.6% |
| 4 | Real Estate | 9.33% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Inovio Pharmaceuticals
INO
$79.9M
| $35K | ﹤0.01% |
1,733
| – | – |
|
2652
ARS Pharmaceuticals
SPRY
$589M
| $35K | ﹤0.01% |
+8,412
| New | +$29.3K |
|
2653
Stock Yards Bancorp
SYBT
$2.61B
| $33K | ﹤0.01% |
+554
| New | +$30.9K |
|
|
JBIO
2654
Jade Biosciences
JBIO
$1.36B
| $32K | ﹤0.01% |
+59
| New | +$28.2K |
|
2655
Design Therapeutics
DSGN
$911M
| $32K | ﹤0.01% |
+2,344
| New | +$31.7K |
|
2656
Editas Medicine
EDIT
$455M
| $32K | ﹤0.01% |
+2,718
| New | +$36.4K |
|
|
BNT
2657
Brookfield Wealth Solutions
BNT
$12.4B
| $32K | ﹤0.01% |
+1,097
| New | +$36.5K |
|
2658
American Coastal Insurance
ACIC
$467M
| $31K | ﹤0.01% |
20,979
-2,512
| -11% | -$5.33K |
|
2659
Gossamer Bio
GOSS
$89.6M
| $31K | ﹤0.01% |
3,798
-36,804
| -91% | -$285K |
|
2660
News Corp Class B
NWS
$17.6B
| $30K | ﹤0.01% |
1,929
+221
| +13% | +$4.12K |
|
2661
PMV Pharmaceuticals
PMVP
$69.3M
| $30K | ﹤0.01% |
+2,141
| New | +$31.2K |
|
2662
Silicom
SILC
$256M
| $30K | ﹤0.01% |
897
-2,026
| -69% | -$72.2K |
|
|
FENG
2663
Phoenix New Media
FENG
$18.1M
| $29K | ﹤0.01% |
6,273
-2,382
| -28% | -$8.61K |
|
2664
The GEO Group
GEO
$4.24B
| $29K | ﹤0.01% |
4,550
-176,664
| -97% | -$1.18M |
|
2665
Trustmark
TRMK
$2.78B
| $29K | ﹤0.01% |
+1,012
| New | +$29.3K |
|
|
WSR
2666
DELISTED
Whitestone REIT
WSR
| $29K | ﹤0.01% |
+2,781
| New | +$33.4K |
|
|
ASRT
2667
DELISTED
Assertio
ASRT
| $28K | ﹤0.01% |
+650
| New | +$27.1K |
|
2668
Geron
GERN
$1.03B
| $28K | ﹤0.01% |
18,187
-8,694
| -32% | -$12.3K |
|
2669
MiMedx Group
MDXG
$633M
| $28K | ﹤0.01% |
+8,300
| New | +$32.5K |
|
2670
Stoke Therapeutics
STOK
$2.1B
| $28K | ﹤0.01% |
+2,170
| New | +$33K |
|
2671
Century Therapeutics
IPSC
$368M
| $27K | ﹤0.01% |
+3,308
| New | +$32.4K |
|
2672
Atea Pharmaceuticals
AVIR
$401M
| $26K | ﹤0.01% |
3,603
-5,939
| -62% | -$40.5K |
|
2673
Fortress Biotech
FBIO
$87.4M
| $26K | ﹤0.01% |
2,080
| – | – |
|
|
SNCR
2674
DELISTED
Synchronoss Technologies
SNCR
| $26K | ﹤0.01% |
2,556
-3,506
| -58% | -$44.4K |
|
|
SQZ
2675
DELISTED
SQZ Biotechnologies Company
SQZ
| $26K | ﹤0.01% |
+8,192
| New | +$29.5K |
|
Similar funds
VAM
Russell Investments Group's Q2 2022 Portfolio in Review
As of Q2 2022, Russell Investments Group held 3,035 positions worth $49B, down 15% from $57.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Russell Investments Group deployed $10.7B of net new capital in Q2 2022, opening 269 new positions and adding to 1,096 existing holdings. Its largest new stake was Bank of America Series L: 6,020,000 shares worth $7.25M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was AT&T, an estimated $94M trimmed.
- Russell Investments Group's largest Q2 2022 buy was Bank of America Series L: 6,020,000 shares worth $7.25M.
- Russell Investments Group added most to Realty Income in Q2 2022, an estimated $93.9M increase.
- Russell Investments Group's biggest Q2 2022 reduction was AT&T, cutting an estimated $94M.
- Russell Investments Group fully exited Cornerstone Building Brands, Inc. in Q2 2022, selling an estimated $34.9M.
- Russell Investments Group's ten largest holdings make up 15% of its $49B portfolio in Q2 2022.
- Russell Investments Group opened 269 new positions and closed 157 in Q2 2022.
- Russell Investments Group's portfolio value fell 15% quarter-over-quarter to $49B.
Based on Russell Investments Group's 13F filing for Q2 2022, filed 29 Jul 2022.